Regentis Biomaterials Raises $15MM for U.S. Pivotal Clinical Trial
Regentis Biomaterials closed a US $15MM Series D investment round. Funds will primarily support a pivotal U.S. clinical trial of GelrinC®, a...
Feb 10, 2016,
Investments
The NumbersEllipse Technologies Withdraws IPO
Ellipse Technologies withdrew its plans for a US $75MM initial public offering, filed in 4Q15, in light of its pending acquisition...
Feb 09, 2016, Julie A. Vetalice
OsteoVantage Receives Grant to Develop INDOS Spinal Instrumentation
OsteoVantage was awarded a US $0.15MM SBIR Phase I grant. Funds will support enhancements to INDOS™, a spinal instrumentation system that employs electroactive...
Jan 21, 2016, Julie A. Vetalice
CartiHeal Raises $15 Million
CartiHeal completed a US $15MM financing round. Funds will support ongoing manufacturing scale-up, EU product commercialization in 2017 and clinical...
Jan 11, 2016, Julie A. Vetalice
Benvenue Medical Secures $60 Million Financing
Benvenue Medical completed a US $60MM financing round. Proceeds will support U.S. commercialization of the Luna® 3D Interbody Fusion and...
Jan 06, 2016, Julie A. Vetalice
Vivex Biomedical Raised $6.6MM in Series A Funding
Vivex Biomedical raised US $6.6MM of a potential $10MM offering of Series A Convertible Preferred Stock. ...
Jan 06, 2016, Julie A. Vetalice
Bone Therapeutics Granted Additional EUR 2MM in Funding
Bone Therapeutics was granted an additional 2MM (~US $2.15MM) in non-dilutive funding, bringing the total non-dilutive funding received within 2015...
Jan 05, 2016, Julie A. Vetalice
Ortho Kinematics Raises $4 Million in Debt Financing
Ortho Kinematics closed US $4MM in debt financing. Funds will support global commercialization of the Vertebral Motion Analysis product for...
Jan 05, 2016, Julie A. Vetalice
Accelus Closes Series D Equity Financing
Proceeds will support further U.S. adoption of Accelus’ spinal and robotic-enabled, minimally invasive techniques....
Jan 01, 1970, Julie A. Vetalice
Loading new posts...
No more posts
